Bobur Kholikov/LinkedIn
Oct 7, 2025, 13:06
Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
Bobur Kholikov, Regional Sales Manager at YHLO, shared a post on LinkedIn:
”iFlash Thrombosis Panel – D-Dimer
D-Dimer is a key biomarker of fibrin degradation, widely used to rule out or confirm thrombosis-related conditions. Elevated levels indicate active clot formation and breakdown, making it a crucial marker in emergency and routine care.
Clinical Value
- Excludes venous thromboembolism (VTE) with high negative predictive value
- Supports diagnosis of DVT, PE, and DIC
- Monitoring of anticoagulant therapy effectiveness
With the iFlash Thrombosis Panel, YHLO provides clinicians with reliable insights into coagulation and fibrinolysis, enhancing early intervention and improving patient outcomes.
Together, make a difference.”
Stay updated with Hemostasis Today.
-
Feb 24, 2026, 16:18Salmaan Dalvi: Mapping Rare Diseases Across East and Central Africa
-
Feb 24, 2026, 16:16Wolfgang Miesbach: Game‑Changing Data on Intensive FVIII Replacement in Haemophilia A with Hypertrophic Synovium
-
Feb 24, 2026, 16:01Is It Safe to Briefly Stop Anticoagulation After VTE? – RPTH Journal
-
Feb 24, 2026, 15:58Anastasia Conti: Honored to Receive the Roche Foundation Grant for Independent Research in Onco-Hematology
-
Feb 24, 2026, 15:55Courtney Lawrence: Targeted Donor Screening Reduces Transfusion-Transmitted Babesia Cases
-
Feb 24, 2026, 15:30Aswin K Mohan: Practical Tips for Preparing Before, During, and After Blood Donation
-
Feb 24, 2026, 15:24Stéphanie Forté: The Hidden Burden of Stroke in Adults Living with Sickle Cell Disease
-
Feb 24, 2026, 15:13Tagreed Alkaltham: Equity in Emergency Care Through a Blood Bank Lens
-
Feb 24, 2026, 14:57Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?